Several major skin care brands like L’Oréal Paris and Proactiv issued a recall of their products due to elevated levels of ...

The recall comes in the wake of concerns over contamination of benzene, news outlet reported. A spokesperson for La ...

In what it says is the biggest obesity deal to date, Zealand Pharma A/S has signed up Roche AG to a potential $5.3 billion global collaboration and license agreement to develop petrelintide, an amylin ...

La Roche-Posay, Walgreens, Proactiv and SLMD Skincare have voluntarily recalled acne treatments from retail that contained ...

Profits and losses for petrelintide and the petrelintide/CT-388 combination will be shared on a 50:50 basis in the U.S. and Europe, while Zealand will be eligible to receive tiered double-digit ...

Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...

Face care products from several popular brands are being recalled over elevated levels of a cancer-causing ingredient.

Viking Therapeutics (VKTX) stock gains as Roche (RHHBY) and Zealand Pharma's (ZLDPF) $5.3B deal for obesity drugs lifts ...

L’Oreal has recalled all U.S. lots of La Roche-Posay Effaclar Duo acne treatment due to concern that it may contain a ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...

President Donald Trump's 25% tariffs on steel and aluminum imports take effect. The latest consumer price index report is due ...